{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nAO2 represented the most effective inhibitor with a closing time of 81\u00b119.5 s, while AO5 was the least effective, with a closing time of 129.5\u00b114.5 s; error bars represent S.E.M.\nVWF aptamer R9.14 was added to 800 microL whole blood at 40 nM concentration, incubated for 5 minutes.\nAO6 completely reverses aptamer function in a PFA-100 assay (black bars) at a 40:1 ratio.\nAO6 achieved complete reversal of aptamer VWF R9.14 function in a PFA-100 assay in 2 minutes, AO6 was used at 40:1 ratio to VWF R9.14 (40 nM).\nThe inhibitory activities of VWF aptamers 9.14, 9.14-T10 and Ch-9.14-T10 were measured at a 50 nM concentration in a PFA-100 assay.\nAll clones were tested in a volume of 840 \u03bcl at a final concentration of 1 \u03bcM (FIG. 3A)."}
{"final_json": [{"molecule_name": "AO2", "protein_target_name": null, "binding_metric": null, "value": "81\u00b119.5", "unit": "s", "is_logarithmic": false}, {"molecule_name": "AO5", "protein_target_name": null, "binding_metric": null, "value": "129.5\u00b114.5", "unit": "s", "is_logarithmic": false}, {"molecule_name": "VWF aptamer R9.14", "protein_target_name": null, "binding_metric": null, "value": "40", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "AO6", "protein_target_name": null, "binding_metric": null, "value": "40:1", "unit": null, "is_logarithmic": false}, {"molecule_name": "AO6", "protein_target_name": null, "binding_metric": null, "value": "2", "unit": "minutes", "is_logarithmic": false}, {"molecule_name": "VWF R9.14", "protein_target_name": null, "binding_metric": null, "value": "40", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "VWF aptamers 9.14", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "VWF aptamers 9.14-T10", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Ch-9.14-T10", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "840", "unit": "\u03bcl", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nTwo-fold serial dilutions of RNA from 1 \u03bcM to 980 \u03c1M were performed and the RNA was incubated in the protein-coated well at 37\u00b0 C. for 45 min.\neither a) buffer, b) cold (unlabeled with <sup>32</sup>P) gpIIb/IIIa RNA, c) Abciximab (Eli Lilly, Indianapolis, Ind.) or d) Eptifibatide (COR Therapeutics Inc, San Fran Francisco, Calif.) was added at two-fold serial dilutions between 100 to 0.1-fold excess of the compound's dissociation constant.\n800 \u03bcL of whole blood was mixed with aptamers in a platelet binding buffer consisting of 150 mM NaCl; 20 mM HEPES pH: 7.4; 5 mM KCl; 1 mM MgCl<sub>2 </sub>and CaCl<sub>2</sub>.\n450 \u03bcl of PRP, 50 \u03bcl of aptamer and 50 \u03bcl Chono-lume were added."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": null}, {"molecule_name": "gpIIb/IIIa RNA", "protein_target_name": "gpIIb/IIIa", "binding_metric": null, "value": "<0.1", "unit": "fold excess", "is_logarithmic": false}, {"molecule_name": "Abciximab", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": null}, {"molecule_name": "Eptifibatide", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "980", "unit": "\u03c1M", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "100", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "0.1", "unit": "fold excess", "is_logarithmic": false}, {"molecule_name": "aptamers", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": null}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nBinding AffinitiesClone VWF R9.14 Kd=12 nM\nThese aptamers bind to VWF with high affinity (K<sub>d</sub>&lt;20 nM) and inhibit platelet aggregation in Platelet Function Analyzer (PFA-100) and ristocetin induced platelet aggregation (RIPA) assays.\nThe Kd of round 9 reached the single digit nanomolar range, thus the individual clones making up the R9RNA pool were cloned and characterized.\nA decreasing K<sub>d </sub>value pointed to increasing affinity of RNA molecules for VWF."}
{"final_json": [{"molecule_name": "VWF R9.14", "protein_target_name": "VWF", "binding_metric": "Kd", "value": "12", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "VWF", "binding_metric": "Kd", "value": "<20", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": null, "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "VWF", "binding_metric": "Kd", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nNone of the sentences in the provided text contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "As shown in FIG. 10C, VWF aptamers R9.3 and R9.14 completely inhibited RIPA (at a concentration of 250 nM), illustrating that the aptamers can potently inhibit the VWF-GP Ib-IX-V interaction.\nMoreover, the antidote is able to completely reverse the antiplatelet effects of the VWF aptamer R9.14 at a 40-fold excess of aptamer concentration. \nThus, antidote AO6 is able to restore platelet function in a whole blood assay back to normal levels, even in the presence of enough VWF aptamer 9.14 (40 nM) to impede platelet function to an extent consistent with VWD."}
{"final_json": [{"molecule_name": "R9.3", "protein_target_name": "VWF", "binding_metric": null, "value": "250", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "R9.14", "protein_target_name": "VWF", "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "R9.14", "protein_target_name": null, "binding_metric": null, "value": "40", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Both clone R9.3 and R9.14 completely inhibited platelet plug formation in PFA-100 at concentrations>40 nM (closing time>300s).\n* Both of these clones inhibited RIPA at >250 nM concentration but had no significant effect in other agonist mediated aggregation assays.\n* Dissociation constants (Kd) of each truncate were determined using double-filter nitrocellulose filter binding assays (Pergolizzi et al, Blood 108:862-869 (2006)). \n\nNote that the third sentence does not contain a specific numeric value for the metric, but it mentions the metric (Kd) and provides a reference to a study where the values might be found. If you only want sentences with specific numeric values, the list would be:\n\n* Both clone R9.3 and R9.14 completely inhibited platelet plug formation in PFA-100 at concentrations>40 nM (closing time>300s).\n* Both of these clones inhibited RIPA at >250 nM concentration but had no significant effect in other agonist mediated aggregation assays."}
{"final_json": [{"molecule_name": "R9.3, R9.14", "protein_target_name": null, "binding_metric": null, "value": ">40", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "R9.3, R9.14", "protein_target_name": null, "binding_metric": null, "value": ">250", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "It was determined that aptamer 9.14 could be truncated from 80 nucleotides to 60 nucleotides without significantly reducing its ability to bind VWF (dissociation constant (Kd) of 44 nM compared to 12 nM for the full length aptamer)"}
{"final_json": [{"molecule_name": "aptamer 9.14", "protein_target_name": "VWF", "binding_metric": "Kd", "value": "44", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "aptamer 9.14", "protein_target_name": "VWF", "binding_metric": "Kd", "value": "12", "unit": "nM", "is_logarithmic": false}]}
